Home GlaxoSmithKline: Unfairly Beaten Given Strategic Direction
 

Keywords :   


GlaxoSmithKline: Unfairly Beaten Given Strategic Direction

2015-10-26 12:51:30| Biotech - Topix.net

GlaxoSmithKline PLC is a global pharmaceutical giant that is trading below intrinsic value. The company's real focus is on scale and innovation - providing much of the world with the drugs and medications it needs while containing an expansive list of patent-protected drugs in late stage development.

Tags: direction strategic beaten glaxosmithkline

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news

»
05.11Registration Now Open for RadTech 2025
05.11Atlantic Tropical Weather Outlook
05.11Eastern North Pacific Tropical Weather Outlook
05.11Tropical Storm Rafael Graphics
05.11Tropical Storm Rafael Public Advisory Number 7A
05.11Summary for Tropical Storm Rafael (AT3/AL182024)
05.11Vodafone-Three merger could get green light, watchdog says
05.11Altice USA residential video RGUs down 77,000 in 3Q 2024
More »